|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1 Park Avenue |
Address2 | 11th Floor |
| City | New York |
State | NY |
Zip Code | 10016 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 54346-12
|
||||||||
|
6. House ID# 350450000
|
||||||||
| TYPE OF REPORT | 8. Year | 2025 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Marc Scarduffa |
Date | 10/20/2025 6:08:01 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
- Request for Delay in the Essential Plan Cuts to New York
- Advocating against hits from the H.R.1 - One Big Beautiful Bill Act (Cap on Provider Taxes)(Limits on SDPs)(Medicaid Work/Eligibility Requirements)(Essential Plan Restrictions)(Affordable Care Act Premium Tax Credits)
- Delay the implementation of sections 112101 and 112102 in HR1
- Engagement with CMS to advance our Suffolk CCN merger request under the site-neutral 35-mile rule exception as well as issues with Medicare Advantage Denials NYULH Suffolk Issues w/Hospital CCN# (Outreach to CMS)
- Support for Dear Colleague Letter on 340B Rebate Model Pilot Program
- Support for Dear Colleague Letter on DSH Cuts
- Support for continuation of funding for Extenders (telehealth, H@H, Community Heath Center Funding, Medicare Site Neutral, Expressing F&A Cap Issues)
- Engagement on NYULH issues around Medicare Advantage Denials/Medicare Site-Neutral Issues
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Marc |
Scarduffa |
|
|
|
Samuel |
Chasin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
- Advocated for Congressional outreach to the CDC in support of the NYU-CUNY Prevention Center grant funding
- Discussed potential impacts of the OBBBA (H.R.1) on NYULH
- Continued support for HHS and NIH funding, and key healthcare extenders such as telehealth, Hospital-at-Home, and community health center funding
- Opposition to Medicaid DSH cuts
- Support for expanding CHGME slots and funding, strengthening pediatric research
- Outreach on support for NYULHs NIDA OPC grant
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Marc |
Scarduffa |
|
|
|
Samuel |
Chasin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
Request for Assistance (Visa Status Delay of NYULH Physician)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Marc |
Scarduffa |
|
|
|
Samuel |
Chasin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
- Requested delay of Essential Plan cuts to New York
- Opposed harmful provisions in H.R.1 (OBBBA) including provider tax caps, limits on SDPs, Medicaid work/eligibility requirements, Essential Plan restrictions, and ACA premium tax credit changes.
- Advocated to delay implementation of Sections 112101 and 112102 of H.R.1.
- Engaged CMS to advance NYULH Suffolks CCN merger request under the 35-mile site-neutral exception and address Medicare Advantage denial issues.
-Supported Dear Colleague Letters on the 340B Rebate Model Pilot Program and DSH cuts.
- Urged continuation of federal extender programs - telehealth, Hospital-at-Home, community health center funding - and addressed concerns on F&A caps and site-neutral policies.
- Promoted sustained HHS and NIH research funding, CHGME slot expansion, and pediatric research investments.
- Advocated for CDC engagement to support NYU-CUNY Prevention Center grant funding.
- Requested support for NYULHs NIDA OPC grant.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Marc |
Scarduffa |
|
|
|
Samuel |
Chasin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |